CNE100001M79
CNE100001M79
FOSUN PHARMA
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q1 '26 31.03.2026 |
|---|---|---|
Market & Enterprise Value | ||
Market Cap | 47.72B EUR | 52.93B EUR |
Enterprise Value | 84.9B EUR | 79.39B EUR |
Valuation Multiples | ||
Trailing P/E | 12.5x | 15.48x |
Forward P/E | 12.95x | -- |
Price to Sales | 1.12x | 1.26x |
Price to Book | 0.83x | 1.08x |
EV/Revenue | 1.99x | 1.9x |
EV/EBITDA | 14.39x | 11.93x |
Price to FCF (P/FCF) | 21.11x | 79.13x |
EV/FCF | 37.56x | 118.7x |
FCF Yield | 4.74% | 1.26% |